In addition to that, CPX-351 activates DNA damage response pathways, including checkpoint kinase 1 (CHK1), and induces cell cycle arrest at the S and G2/M phases, further promoting apoptosis in AML cells. This evidence concerns the gene CHEK1 and acute myeloid leukemia.